Given the lumpy revenue, current cash balance, and next quarters outgoings it looks like a CR will be coming sooner rather than later.
The company looks to be progressing well on the technology front which should translate into winning more customers or increasing the monthly revenue from existing customers.
- Forums
- ASX - By Stock
- 3DP
- Ann: Appendix 4C - quarterly
Ann: Appendix 4C - quarterly, page-5
Featured News
Add 3DP (ASX) to my watchlist
(20min delay)
|
|||||
Last
4.0¢ |
Change
-0.003(6.98%) |
Mkt cap ! $32.20M |
Open | High | Low | Value | Volume |
4.2¢ | 4.3¢ | 4.0¢ | $50.93K | 1.230M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
6 | 825024 | 4.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
4.2¢ | 264207 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 175024 | 0.040 |
3 | 1240758 | 0.039 |
6 | 327131 | 0.038 |
2 | 120000 | 0.037 |
3 | 300300 | 0.036 |
Price($) | Vol. | No. |
---|---|---|
0.043 | 78979 | 1 |
0.045 | 104682 | 2 |
0.046 | 19786 | 2 |
0.047 | 5505 | 1 |
0.048 | 12837 | 1 |
Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
Featured News
3DP (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online